NA Proactive news snapshot: WeedMD, Gold Resource Corporation, EnWave, Royal Road Minerals, OTC Markets Group, Gold Resource UPDATE …

WeedMD Inc (CVE:WMD) (OTCQX:WDDMF) told shareholders on Wednesday it is kicking off its second outdoor cultivation season at its flagship Strathroy, Ontario facility. The Toronto-based company will grow cannabis at the 27-acre outdoor field, with clones planted by early June and harvested throughout the fall of 2020. WeedMD said that all infrastructure and staffing resources are onsite with a team fully versed in outdoor grow operations. Gold Resource Corporation (NYSEAMERICAN:GORO) said Wednesday that Mexico has extended its national health emergency until May 30 to help stop the spread of coronavirus. GORO’s operations in Oaxaca remain temporarily closed in accordance with the declaration, although the company said it is working on a plan for a staged ramp-up of operations utilizing local workforce once it receives government permission to restart mining. According to GORO’s statement, Mexico’s government signaled its intention to evaluate zones with relatively low cases of coronavirus for a possible earlier startup.  EnWave Corporation (CVE:ENW) (OTCPINK:NWVCF) has signed a technology evaluation and license option agreement with a food company based in South America to evaluate potential commercial use of its Radiant Energy Vacuum (REV) dehydration technology.  The unnamed food company will pay a monthly evaluation fee and have the exclusive option to obtain a royalty-bearing commercial license agreement to use REV technology in the production of food products. EnWave will lease the company a 10 kilowatt REV machine for use at its research and development facility during the term of the deal to conduct product development alongside EnWave’s food scientists. Royal Road Minerals Limited (CVE:RYR) said Wednesday it had signed an agreement with the proprietors of an informal gold mine, La Esmerelda, to establish mining operations. The agreement, signed through Royal Road’s Colombian subsidiary Exploraciones Northern Colombia SAS (ENC), will enable legal and responsible mining operations to resume at La Esmerelda, located in the Nariño district, Colombia within a concession contract held by AngoGold Ashanti. Royal Road will return a specified portion of the area under the concession so that a new concession contract can be granted by Colombia’s Ministry of Mines and Energy, the company said in a statement. OTC Markets Group Inc (OTCQX:OTCM) announced on Wednesday that Canadian companies traded on the OTCQX and OTCQB markets are now providing reliable current share data through their registered transfer agents directly to OTC Markets. In a statement, the New York-headquartered group said nine transfer agents serving Canadian companies recently joined the Transfer Agents Verified Shares program bringing the total number of participating transfer agents to 45, representing over 1,200 US and Canadian securities traded on the OTCQX and OTCQB markets. "This innovative process allows OTCQX and OTCQB companies to provide their shareholders with more trusted and timely information in an efficient manner," said OTC Markets Group CEO R Cromwell Coulson in a statement. Roth Capital Partners on Wednesday reiterated its Buy rating on Gold Resource Corporation (NYSEAMERICAN:GORO) following the miner’s first-quarter production results and expectations for a "strong" second half of 2020. The gold and silver producer, developer and explorer with mining operations in Mexico and Nevada announced April 20 that it produced 10,142 ounces of gold and 407,625 of silver during the first three months of 2020. That said, a Roth analyst noted that while production came in below estimates amid the coronavirus (COVID-19) shutdowns, it expects a turnaround later in the year. “While production was modestly below expectations during 1Q20, we expect production to steadily ramp up into 2H20, which we expect to support strong cash flow generation in the second half of the year,” wrote analyst Jake Sekelsky. Champignon Brands Inc (CSE:SHRM) (OTCMKTS:SHRMF) said Wednesday that it has advanced its clinical pipeline through a long-term supply of psilocybin for its ongoing traumatic brain injury (TBI) and post-traumatic stress disorder (PTSD) preclinical studies at the University of Miami’s Miller School of Medicine. In a statement, the Vancouver-based company which is positioning itself as a leader in the burgeoning psychedelics space, said that its research partner and lead investigator, Dr Michael Hoffer, has secured “a sustainable supply” of psilocybin under a Drug Enforcement Administration (DEA) schedule I license, which will be used for ongoing psilocybin-based therapeutics studies. Surge Holdings Inc (OTCQB:SURG) on Wednesday reported record unaudited sales of $2.98 million for March within its wholly-owned subsidiary Surge Logics. The company pointed out that compared to sales of $1.35 million in February 2020 and just $319,012 for March 2019, illustrating growing demand for its products and services as its customer base expands. Empower Clinics Inc (CSE:CBDT) (OTCQB:EPWCF), the CBD product producer and wellness clinic operator, has created a subsidiary company focused on psilocybin research and psychedelics therapy in the treatment of mental health issues. To get there, the company is leveraging its existing clinic network, which boasts some 165,000 patients and a robust team of physicians, along with its franchise CBD brand and telemedicine capabilities. Kincora Copper Ltd. (CVE:KCC) announced it has commenced drilling activities at the Trundle project, located in the Macquarie Arc of the Lachlan Fold Belt in central west New South Wales, Australia. It said a first phase drilling program is planned for six holes and 3,800 metres, testing three known mineralized targets seeking to discover a new cluster of porphyry deposits. Extensive porphyry and skarn-style copper-gold mineralisation and informal mining activities are associated with several Ordovician intrusive centres across the full Trundle license, which is located within a prolific mining and infrastructure district. Q BioMed Inc (OTCQB:QBIO) and its technology partner Mannin Research are accelerating the rapid development of novel drugs for the treatment of life-threatening complications caused by coronavirus (COVID-19) and other viral infections. The New York City-based company said this novel drug program is being evaluated by government programs for funding and accelerated development under various COVID-19 response initiatives. Q BioMed and Mannin hope to have at least one treatment in human trials this year, according to a statement Wednesday. Algernon Pharmaceuticals Inc (CSE:AGN) (OTCQB:AGNPF) said it has submitted a Clinical Trial Application to Health Canada for a Phase 2b/3 multinational clinical trial using NP-120, known as Ifenprodil, as a coronavirus (COVID-19) therapy. In a statement Wednesday, the company said the same study protocol is being prepared for submission to the US Food and Drug Administration and Australian regulatory authorities. Group Eleven Resources Corp (CVE:ZNG) (OTCMKTS:GRLVF) has strengthened its project pipeline with the addition of two advanced copper-silver prospects at its flagship Stonepark and PG West property in Ireland. The Vancouver-based company obtained prospecting licenses for the Denison and Tullacondra projects, both of which host historic mineral estimates that provide potential for new discovery. The additions complement the company's existing Gortdrum and Oola copper-silver prospects at the PG West Project, which is located in the Limerick basin. XPhyto Therapeutics Corp (CSE:XPHY) (OTCPINK:XPHYF) has revealed that no time has been wasted following the deal struck with German firm 3a-Diagnostics - announced on Monday - to develop and commercialize oral screening tests for infectious diseases, including coronavirus (COVID-19). XPhyto said its German subsidiary, Vektor Pharma has taken delivery of certain peptide biosensors from 3a to adapt them for use with Vektor's oral dissolvable thin film (ODF) platform. Cabral Gold Inc (CVE:CBR) (OTCMKTS:CBGZF) has identified a new high-grade gold target at its Cuiú Cuiú project in Brazil, it said Wednesday. The new target, Medusa, gets its name from airborne magnetic data that suggests a complex structural setting located within the main regional TZ fault zone that hosts a major gold deposit. Block sampling at Medusa returned gold values ranging between 1.1 and 82.1 grams per ton, with 13 samples averaging 26 grams per ton, and 5.2 to 50.1 grams per ton, and six samples averaging 21.8 grams per ton gold. Mota Ventures Corp (CSE:MOTA) (OTCMKTS:PEMTF) said it has raised around an additional C$2.8 million via a private placing, having already brought in C$1.72 million earlier this month from another offering. In the latest financing, the group issued over 9.9 million units at C$0.28 each to raise C$2,784,320 gross. Mirasol Resources Ltd (CVE:MRZ) (OTCMKTS:MRZLF) has unveiled encouraging drill assays from the Atlas target at the Gorbea Gold project in Chile by Newcrest Mining (ASX:NCM), where the option period has been extended by six months. Mirasol is a project generator and its portfolio includes nearly 40 gold, silver and precious metal projects in Chile and Argentina. Agile Therapeutics Inc (NASDAQ:AGRX), the women’s health care company behind the Twirla contraceptive patch, announced Wednesday that it plans to welcome two new faces to its board of directors.  The company said it has nominated Sharon Barbari, a 40-year pharmaceutical and biotechnology industry veteran, for election as a class III director on the board. Barbari has served in several senior financial roles, including CFO at Cytokinetics, InterMune and Gilead Sciences. Agile said it also plans to appoint Sandra Carson as a class II director to replace the reiting William McKee.  Carson is a professor of obstetrics, gynecology and reproductive sciences and the reproductive endocrinology and infertility director at Yale. She most recently served as emeritus vice president for education at the American College of Obstetricians & Gynecologists Ideanomics Inc (NASDAQ:IDEX), the greentech and Fintech advisory group, said its Mobile Energy Global (MEG) subsidiary is poised to provide electricity services for projects which include 5G towers and new energy vehicle charging piles in China. It comes after Qingdao Enengju New Energy Sales and Service Co Ltd (Enengju) inked a strategic co-operation agreement with Zhongsen Tower Communications to build and operate new infrastructure projects. Capstone Turbine Corporation (NASDAQ:CPST), the maker of clean-energy microturbines, said it will participate in the alphaDIRECT Virtual Conference Series to discuss the company's preliminary fiscal fourth-quarter results for 2020 and provide an update on its coronavirus (COVID-19) business continuity plan. The presentation, scheduled for 2.00pm ET on April 23, will be made by Capstone Turbine CEO Darren Jamison and CFO Eric Hencken. Their talk will be followed by a short question and answer session. The presentation will be webcast live and available for replay at Capstone’s website www.capstoneturbine.com and under the alphaDIRECT investor center at http://www.alphadirectadvisors.com. IEC Electronics Corp. (NASDAQ:IEC) has announced that it will host a conference call on Wednesday, May 6, 2020 at 10.00am Eastern Time, to discuss its financial results for the fiscal second quarter of 2020, ended March 31, 2020. The conference call may be accessed in the US and Canada by dialing toll-free (877) 407-9210; International callers may access the call by dialing (201) 689-8049. A replay of the teleconference will be available for 30 days after the call and may be accessed domestically by dialing (877) 481-4010 and international callers may dial (919) 882-2331. Callers must enter conference ID: 34135. To access the live webcast, log onto the IEC website at http://www.iec-electronics.com. The webcast can also be accessed at http://www.investorcalendar.com/event/34135. An online replay will be available shortly after the call. Virtual Investor Conferences, the leading proprietary investor conference series, has said the presentations from KCSA's Cannabis and Psychedelics conference on April 20 are now available for on-demand viewing at VirtualInvestorConferences.com. It noted that the presenting companies were: Field Trip Psychedelics Inc; Psybio Therapeutics, Inc.; Eleusis Ltd.; Back of the Yards Algae Sciences; ATAI Life Sciences AG; Fire & Flowers Holding Corp. (OTCQX:FFLWF) (TSX:FAF); 4Front Ventures Corp (OTCQX:FFNTF) (CSE:FFNT) MariMed Inc. (OTCQX:MRMD); The Valens Company (OTCQX:VLNCF) (TSX:VLNS); MediPharm Labs Corp. (OTCQX:MEDIF) (TSX:LABS); and Tabula Rasa Ventures. Virtual Investor Conference, part of OTC Market Inc's (OTCQX:OTCM) suite of investor relations services, is the leading proprietary investor conference series that provides an interactive forum for publicly-traded companies to meet and present directly with investors.